Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers

NCT01292174 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of Infection With HIV-1

Interventions

BIOLOGICAL: ibalizumab (biologic/MAb) for SC Injection or placebo
BIOLOGICAL: ibalizumab (biologic/MAb) for SC Injection or placebo
BIOLOGICAL: ibalizumab (biologic/MAb) for SC Injection or placebo

Sponsor

TaiMed Biologics Inc.

Collaborators

[object Object]
[object Object]